Seven Eight Capital, LP Abbott Laboratories Transaction History

Seven Eight Capital, LP

$1.05 Billion
Q3 2024

A detailed history of Seven Eight Capital, LP transactions in Abbott Laboratories stock. As of the latest transaction made, Seven Eight Capital, LP holds 6,732 shares of ABT stock, worth $768,996. This represents 0.07% of its overall portfolio holdings.

Number of Shares

6,732

Previous 39,850 83.11%

Holding current value

$768,996

Previous $4.14 Million 81.47%

% of portfolio

0.07%

Previous 0.45%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $3.31 Million - $3.91 Million	-33,118 Reduced 83.11%	6,732 $767,000
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $2.61 Million - $2.91 Million	25,878 Added 185.21%	39,850 $4.14 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $1.08 Million - $1.19 Million	9,857 Added 239.54%	13,972 $1.59 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $658,387 - $805,920	-7,300 Reduced 63.95%	4,115 $452,000
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $1.24 Million - $1.49 Million	-12,960 Reduced 53.17%	11,415 $1.11 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $887,771 - $989,162	8,809 Added 56.59%	24,375 $2.66 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $1.51 Million - $1.77 Million	15,566 New	15,566 $1.58 Million
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $4.24 Million - $5.12 Million	-41,532 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $4.74 Million - $5.77 Million	41,532 New	41,532 $4.92 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $962,942 - $1.18 Million	-8,335 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $972,361 - $1.08 Million	8,335 New	8,335 $985,000
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $1.38 Million - $1.63 Million	-13,055 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $1.37 Million - $1.49 Million	13,055 New	13,055 $1.43 Million
Q2 2020 Aug 06, 2020	SELL	$76.57 - $98.0 $6.08 Million - $7.78 Million	-79,400 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $4.99 Million - $7.29 Million	79,400 New	79,400 $6.27 Million
Q2 2018 Aug 07, 2018	SELL	$57.57 - $63.54 $714,558 - $788,658	-12,412 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $698,423 - $789,651	12,412 New	12,412 $744,000
Q4 2017 Feb 12, 2018	SELL	$53.68 - $57.47 $4.79 Million - $5.13 Million	-89,212 Closed	0 $0
Q3 2017 Oct 16, 2017	BUY	$48.06 - $53.64 $4.29 Million - $4.79 Million	89,212	89,212 $4.76 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Account

Seven Eight Capital, LP Abbott Laboratories Transaction History